However, increasing evidence suggests that ccRCC response to immunotherapy was independent of the extent of CD8+ T cell infiltration and PD-L1 expression (11) and could not be predicted by tumor mutational burden (TMB), as done in some other cancers (12, 13). Here, CD274 is linked to nonpapillary renal cell carcinoma.